Image

Global Digital Pills Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Upcoming Report
  • Mar 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Digital Pills Market, By Product Type (Tablet, Capsule, Microchip Delivery Device), Indication (Mental Disorders, Cancer, Infectious Diseases, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Mail Order Pharmacies), Diseases (Cardiovascular Diseases, Infectious Diseases, Diabetes, Cancer, Others), End-User (Hospitals, Clinics, Home Care Settings, Others) – Industry Trends and Forecast to 2029.

Digital Pills Market

Global Digital Pills Market Analysis and Size

The market for digital pills is estimated to grow rapidly over the forecast period. Ingestible sensors in pharmaceuticals will revolutionize the patient compliance problem. Medication or prescription compliance is also an issue for mentally ill patients. Many older individuals find it difficult to maintain track of their medications simply because they forget to take them. Currently, digital tablets are regulated as digital medicine. Oral chemotherapy compliance could benefit greatly from the use of digital pills.

  • Data Bridge Market Research analyses that the digital pills market was valued at USD 3.64 billion in 2021 and is expected to reach USD 6.91 billion by 2029, registering a CAGR of 8.35 % during the forecast period of 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Global Digital Pills Market Definition

Digital pills are ingestible sensors that are attached to a small wearable skin sensor patch that transfers the collected data to a connected digital device including a smartphone. The information gathered from digital pills is saved, and patients can share it with their doctors and caregivers.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Product Type (Tablet, Capsule, Microchip Delivery Device), Indication (Mental Disorders, Cancer, Infectious Diseases, Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, Mail Order Pharmacies), Diseases (Cardiovascular Diseases, Infectious Diseases, Diabetes, Cancer, Others), End-User (Hospitals, Clinics, Home Care Settings, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

Market Players Covered

2morrow Inc. (US), Otsuka Holdings Co., Ltd. (Japan), Pure Tech (US), Teladoc Health, Inc. (US), AliveCor, Inc.(US), Abbott (US), Olympus Corporation (Japan), Medtronic (Ireland), Smith+Nephew (UK), Novartis AG (Switzerland), Omada Health Inc. (US), Mocacare (California), GENTAG, Inc. (US),Zio by iRhythm Technologies, Inc. (US), Perficient Inc. (US), BDD Ltd (UK), CapsoVision, Inc. (USA), Ginger (US), Teladoc Health, Inc. (US), Welldoc, Inc. (US)

Digital Pills Market Dynamics

Drivers

  • Increasing prevalence of chronic disorders will drive the market’s growth rate.

The prevalence of chronic disorders such as diabetes and other cardiovascular diseases will enhance the adoption rate of digital pills and further influence the market dynamics during the forecast period of 2022-2029.

  • Rising application of medicine adherence and patient compliance will propel the growth rate of market during the forecast period. 

Digital pills are now more commonly used to track medication adherence or patient compliance. They could also be used to collect data in clinical trials. Hence this will flourish the growth rate of digital pills market.  

Furthermore, decreased expenses from wasted medications will act as a major factor influencing the growth of digital pills market. Along with this, favourable reimbursement policies and rising disposable income are the driving factors accelerating the growth of the digital pills market. Also, the rise in the changing lifestyle and increasing expenditure on healthcare infrastructure are the major market drivers that will further escalate the growth of digital pills market. Another significant factor that will cushion the digital pills market’s growth rate is the faster recovery times from greater adherence to treatment regimens and quick results. In addition to this, growing development in endoscopy processes and monitoring the results of patients irrespective of location will cushion the growth rate of digital pills market.

Opportunities

  • Growing R&D activities will boost many market opportunities during the forecast period. 

Moreover, the rising number of research and development activities coupled with high level of investments will provide beneficial opportunities for the digital pills market growth.

Moreover, increasing technological advancements and modernization in healthcare devices will further provide beneficial opportunities for the digital pills market growth.

Restraints/Challenges Global Digital Pills Market

  • Low adoption rate of digital pills will hamper the market’s growth rate.

However, due to a number of problems such as uncertain legislation, long-term adverse effects, and the possibility of data privacy breach, digital pill acceptance is still minimal. Hence, this will impede the digital pills market’s growth rate.

On the other hand, the dearth of skilled professionals in healthcare sector will challenge the digital pills market. Additionally, high cost associated with technological advancement and the dearth of awareness will act as restrain and further impede the growth rate of market during the forecast period of 2022-2029.

This digital pills market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the digital pills market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

COVID-19 Impact on Digital Pills Market

The COVID-19 pandemic has resulted in unforeseen consequences such as significant delays in disease detection and treatment. According to the Commonwealth Fund, COVID-19 is expected to result in a roughly 60% reduction in overall outpatient visits by the month of May 2020. Because digital tablets are frequently given to patients in hospitals, this was predicted to have a negative impact on demand. Ingestible sensors in pharmaceuticals will revolutionize the patient compliance problem. Medication or prescription compliance is also an issue for mentally ill patients. Many older individuals find it difficult to maintain track of their medications simply because they forget to take them. Hence, COVID-19 had a negative impact on digital pills market. 

Global Digital Pills Market Scope

The digital pills market is segmented on the basis of product type, indication, distribution channel, diseases and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

  • Tablet
  • Capsule
  • Microchip Delivery Device

On the basis of product type, digital pills market is segmented into tablet, capsule and microchip delivery device.

Indication

  • Mental Disorders
  • Cancer
  • Infectious Diseases
  • Others

Based on indication, the digital pills market is segmented into mental disorders, cancer, infectious diseases and others.

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • Mail Order Pharmacies

Based on distribution channel, the digital pills market is segmented into hospital pharmacies, retail pharmacies, specialty pharmacies and mail order pharmacies.

Diseases

  • Cardiovascular Diseases
  • Infectious Diseases
  • Diabetes
  • Cancer
  • Others

Based on diseases, the digital pills market is segmented into cardiovascular diseases, infectious diseases, diabetes, cancer and others.

End-User

  • Hospitals
  • Clinics
  • Home Care Settings
  • Others

On the basis of end user, the digital pills market is segmented into hospital, clinics, home care settings and others.

Digital Pills Market Regional Analysis/Insights

The digital pills market is analysed and market size insights and trends are provided by country, product type, indication, distribution channel, diseases and end-user as referenced above.

The countries covered in the digital pills market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the digital pills market because of the growing adoption of advanced technologies by manufacturers in tracking tools and increase in R&D investments in this region.   Additionally, rising prevalence of diseases such as diabetes and other cardiovascular disorders and increase in faster recovery times from greater adherence to treatment regimens in this region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The digital pills market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for digital pills market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the digital pills market. The data is available for historic period 2010-2020.

Competitive Landscape and Digital Pills Market Share Analysis

The Digital pills market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to digital pills market.

Some of the major players operating in the digital pills market are 2morrow Inc. (US), Otsuka Holdings Co., Ltd. (Japan), Pure Tech (US), Teladoc Health, Inc. (US), AliveCor, Inc.(US), Abbott (US), Olympus Corporation (Japan), Medtronic (Ireland), Smith+Nephew (UK), Novartis AG (Switzerland), Omada Health Inc. (US), Mocacare (California), GENTAG, Inc. (US),Zio by iRhythm Technologies, Inc. (US), Perficient Inc. (US), BDD Ltd (UK), CapsoVision, Inc. (USA), Ginger (US), Teladoc Health, Inc. (US), Welldoc, Inc. (US), among others.

Research Methodology : Global Digital Pills Market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-digital-pills-market

Customization Available : Global Digital Pills Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions

The Market Value for Digital Pills Market in 2021 is expected USD 6.91 billion by 2029.
The Digital Pills Market is to Grow at a CAGR of 8.35% During the Forecast Period of 2022 to 2029.
Otsuka Holdings Co., Ltd. (Japan), Pure Tech (US), Teladoc Health, Inc. (US), AliveCor, Inc.(US), Abbott (US), Olympus Corporation (Japan), Medtronic (Ireland), Smith+Nephew (UK), Novartis AG (Switzerland), and Omada Health Inc. (US) are the Major Companies Operating in Digital Pills Market.
The Countries Covered in the Digital Pills Market Report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
The Digital Pills Market Report Curated by the Data Bridge Market Research Team Includes In-Depth Expert Analysis, Patient Epidemiology, Pipeline Analysis, Pricing Analysis, and Regulatory Framework.